[DPHARMA] Change In Substantial Shareholder's Shareholding - EMPLOYEES PROVIDENT FUND BOARD on 23-Dec-2021

Highlights

Stock	[DPHARMA]: DUOPHARMA BIOTECH BERHAD
Announcement Date	23-Dec-2021

Name	EMPLOYEES PROVIDENT FUND BOARD

Currency

	Type	Number of Shares
20-Dec-2021	Acquired	400,000
Registered Name	Citigroup Nominees (Tempatan) Sdn. Bhd
Nature of Interest	Direct Interest

Nature of Interest	Indirect Interest
Shares	Ordinary Shares
Reason	Acquisition of 400,000 shares by Citigroup Nominees (Tempatan) Sdn. Bhd. - Employees Provident Fund Board (AM INV)

Be the first to like this.

TOP ARTICLES

1.	Unveiling YTL's AI Supercomputer (KingKKK): A Catalyst for Malaysian Digital Economy Growth? YTL, YTLPOWR Stock Market Enthusiast
2.	Stock on Radar - YTL Corporation AmInvest Research Reports
3.	Why detractors silent about PMX’s latest Saudi trip to attend WEF after whipping up a storm on his maiden trip save malaysia!
4.	Make EPF account restructuring a step towards a more comprehensive pension reform — Hawati Abdul Hamid and Puteri Marjan Megat Muzafar save malaysia!
5.	Weekly Strategy - Buying Support Needed to Cushion Negative External News Flows TA Sector Research
6.	Should “stakeholders” sue Bloomberg to prove 2nd casino licence claim for Johor’s Forest City is “sheer slander”? save malaysia!
7.	Trade-related and ESG measures must be fair to developing countries - Tengku Zafrul save malaysia!
8.	Daily Market Commentary - 29 Apr 2024 TA Sector Research

APPS

I3 Messenger

Individual or Group chat with anyone on I3investor

MQ Trader

Stock Screener using Technical and Fundamental criteria

MQ Affiliate

Join the MQ Affiliate Program today to earn rewards

574

347

659

790

ActiveGainersLosers

PARTNERS & BROKERS